PUBLISHER: The Business Research Company | PRODUCT CODE: 1969982
PUBLISHER: The Business Research Company | PRODUCT CODE: 1969982
The utilization of advanced algorithms, machine learning techniques, and other artificial intelligence (AI) technologies in medical devices aims to enhance their performance and capabilities. This integration of AI in medical devices contributes to improved diagnostic accuracy, assistance in surgical procedures, prediction of patient outcomes, and the personalization of treatment plans.
AI in medical devices can be deployed through two main methods, cloud and on-premise. Cloud deployment involves utilizing a remote server network for data storage, processing, and management over the Internet, as opposed to relying on a local server or personal computer. This approach encompasses various technologies such as context awareness, deep learning, machine learning, natural language processing, predictive analytics, among others. These technologies find applications in diverse areas such as patient care, treatment, diagnosis, monitoring, and more. The primary end-users of AI in medical devices include hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, as well as healthcare payers.
Tariffs have affected the AI in medical devices market by increasing costs of imported sensors, semiconductors, imaging components, and specialized hardware. These cost pressures are more evident for imaging devices, surgical robots, and monitoring equipment, particularly in north america and europe. Higher production costs have slowed device upgrades for hospitals and healthcare providers. However, tariffs have encouraged localized manufacturing and regional supply chain development. This has supported long-term resilience and innovation in ai-enabled medical device production.
The AI in medical devices market research report is one of a series of new reports from The Business Research Company that provides AI in medical devices market statistics, including AI in medical devices industry global market size, regional shares, competitors with a AI in medical devices market share, detailed AI in medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the AI in medical devices industry. This AI in medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The AI in medical devices market size has grown exponentially in recent years. It will grow from $12.38 billion in 2025 to $16.16 billion in 2026 at a compound annual growth rate (CAGR) of 30.5%. The growth in the historic period can be attributed to advancements in medical device technology, rising burden of chronic diseases, growing adoption of digital health solutions, increasing healthcare automation, demand for accurate diagnostics.
The AI in medical devices market size is expected to see exponential growth in the next few years. It will grow to $42.43 billion in 2030 at a compound annual growth rate (CAGR) of 27.3%. The growth in the forecast period can be attributed to integration of AI in clinical workflows, growing investment in smart healthcare infrastructure, rising demand for personalized treatment, expansion of remote patient monitoring, increasing regulatory approvals for AI devices. Major trends in the forecast period include ai-enabled diagnostic devices, intelligent surgical assistance systems, predictive patient monitoring devices, smart wearable medical devices, clinical decision support integration.
The rising demand for personalized medicine is anticipated to drive the growth of AI in the medical devices market in the future. Personalized medicine is a tailored healthcare approach that considers individual patient characteristics, such as genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. Several factors contribute to the increasing demand for personalized medicine, including advancements in genomics, greater patient empowerment, and enhanced treatment efficacy. AI processes vast amounts of patient data, encompassing genetic information, medical histories, and lifestyle factors, to develop a comprehensive understanding of individual profiles, which in turn supports the creation of customized treatment plans. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported in February 2024 that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is a key driver of growth for AI in the medical devices market.
Major players operating in the AI in medical devices market are emphasizing strategic collaborations to speed up the advancement of AI within the healthcare system and strengthen their competitive position. These partnerships are intended to leverage AI capabilities to enhance drug discovery, design, and development, as well as to improve medical device manufacturing efficiency and minimize risks through machine learning. For instance, in March 2023, Medtronic, an Ireland-based medical device company, collaborated with NVIDIA Corporation, a US-based software company, to develop an AI platform for medical devices. Through this collaboration, the companies planned to integrate NVIDIA's healthcare and edge AI technologies into the GI Genius intelligent endoscopy module developed and manufactured by Cosmo Pharmaceuticals for Medtronic. GI Genius, the first AI-assisted colonoscopy tool approved by the FDA, helps physicians detect polyps that could potentially progress into colorectal cancer. Accordingly, this strategic collaboration is intended to accelerate the deployment of AI in the healthcare system and introduce new AI-driven solutions into patient care.
In February 2023, GE HealthCare Technologies Inc., a US-based healthcare technology and diagnostics company, completed the acquisition of Caption Health Inc. for $3 billion. This acquisition was driven by the goal of expanding the use cases of Caption AI, developed by Caption Health Inc., beyond cardiology to various medical specialties such as primary care, emergency medicine, and obstetrics. Caption Health Inc. is recognized for its expertise in producing AI medical products, and this acquisition positions GE HealthCare Technologies Inc. to bring AI innovations to a broader range of clinicians and medical specialties.
Major companies operating in the AI in medical devices market are General Electric Company; Medtronic plc; Siemens Healthineers AG; Nvidia Corporation; Intel Corporation; International Business Machines Corporation; Koninklijke Philips N.V.; Enlitic Inc.; Cloudmedx Inc.; Oncora Medical Inc.; Path AI Inc.; Aidoc Medical Ltd.; Accuray Incorporated; AliveCor; Arterys Inc.; Augmedics Inc.; Brainomix Ltd.; Butterfly Network Inc.; Canon Medical Systems Corporation; CureMetrix Inc.
North America was the largest region in the AI in medical devices market in 2025. The regions covered in the AI in medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the AI in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI in medical devices market consists of revenues earned by entities by providing AI in medical devices such as diagnosis and treatment planning, remote monitoring, and robotic surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in medical devices market also includes sales of diagnostic imaging systems, wearable devices, electronic health records (EHRs), robotic surgical systems, and AI monitoring devices, which are used in providing AI in medical devices services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Medical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses AI in medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for AI in medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The AI in medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.